Chandigarh-based Nectar Lifesciences Ltd, a manufacturer and exporter of sterile
semi synthetic penicillin in India, is raising funds to be used for financing
its formulations facility at Baddi in Himachal Pradesh, a R&D center and
corporate quality control center. At present its investment into R&D
activities is about Rs 5-6 crore and it is keen to invest Rs 25 crore in
developing the R&D center that will facilitate contract research work from
other companies.